Clinical Trial Update: Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy [Phase 4]

View source ↗

Summary

A Phase 4 multicenter prospective study evaluated changes in sexual function in men treated with alfuzosin (Xatral XL) for benign prostatic hyperplasia and lowe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Lower Urinary Tract Symptoms

Drugs mentioned

• Xatral XL (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: BPH/LUTS/Sexual Functions | Phase 4 | Status: COMPLETED